Buy Monsanto ( MON), Jim Cramer said on CNBC's "Stop Trading!" segment Friday. "This is a market where you have to stay with what is ... left of the winners," Cramer said. "Oil, agriculture, infrastructure." For a tech play, Cramer recommended Microsoft ( MSFT), but noted that "it's being pulled down by the cohort." Cramer remains pessimistic about the broader market. "This has got a very bad feel to it. ... I just don't like this market at all." Cramer welcomed Monsanto Executive Vice President and Chief Technology Officer Rob Fraley to the show. Of the company's Smartstax venture, Cramer said, " Allergan's ( AGN) got nothing to top this." "It's all about yield," Fraley said of Monsanto's mission. "We're really a biotech company that delivers higher yielding corn and soybean and cotton." He credits the agricultural products developer's unique innovation for the company's success. Cramer noted Monsanto's unusual level of patent protection. "We have tremendous breeding, and we are invested early on in this biotechnology area," Fraley replied. He believes that improved "opportunities for Asia markets and also for biofuel production" will sustain the company. Monsanto recently developed seeds that require less water. Fraley believes that these seeds will help improve efficiency in processes that include the production of ethanol.